Skip to content
10-Q

Quarterly Report

ABIOMED INC

0000950170-22-021880

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Oct 28, 2022 45.09M sh
Shares Diluted Q2 2023 · Sep 30, 2022 45.71M sh
Shares Diluted Q2 2023 · Sep 30, 2022 45.81M sh
Shares Diluted Q2 2023 · Sep 30, 2021 45.89M sh
Shares Diluted Q2 2023 · Sep 30, 2021 45.86M sh
Stock Repurchased Q2 2023 · Sep 30, 2022 $126.62M
Stock Repurchased Q2 2023 · Sep 30, 2021 $0
Capex Q2 2023 · Sep 30, 2022 $12.39M
Capex Q2 2023 · Sep 30, 2021 $14.39M
Operating Cash Flow Q2 2023 · Sep 30, 2022 $81.52M
Operating Cash Flow Q2 2023 · Sep 30, 2021 $115.93M
Cash And Equivalents Q2 2023 · Sep 30, 2022 $182.34M
Cash And Equivalents Q2 2023 · Mar 31, 2022 $132.82M
Stockholders Equity Q2 2023 · Sep 30, 2022 $1.54B
Stockholders Equity Q2 2023 · Jun 30, 2022 $1.54B
Stockholders Equity Q2 2023 · Mar 31, 2022 $1.5B
Stockholders Equity Q2 2023 · Sep 30, 2021 $1.38B
Stockholders Equity Q2 2023 · Jun 30, 2021 $1.31B
Stockholders Equity Q2 2023 · Mar 31, 2021 $1.33B
Current Liabilities Q2 2023 · Sep 30, 2022 $134.06M
Current Liabilities Q2 2023 · Mar 31, 2022 $138.46M
Total Liabilities Q2 2023 · Sep 30, 2022 $156.76M
Total Liabilities Q2 2023 · Mar 31, 2022 $170.07M
Current Assets Q2 2023 · Sep 30, 2022 $1.06B
Current Assets Q2 2023 · Mar 31, 2022 $976.47M
Total Assets Q2 2023 · Sep 30, 2022 $1.7B
Total Assets Q2 2023 · Mar 31, 2022 $1.67B
Eps Diluted Q2 2023 · Sep 30, 2022 $2.32
Eps Diluted Q2 2023 · Sep 30, 2022 $3.51
Eps Diluted Q2 2023 · Sep 30, 2021 $1.24
Eps Diluted Q2 2023 · Sep 30, 2021 $0.66
Eps Basic Q2 2023 · Sep 30, 2022 $2.34
Eps Basic Q2 2023 · Sep 30, 2022 $3.53
Eps Basic Q2 2023 · Sep 30, 2021 $1.25
Eps Basic Q2 2023 · Sep 30, 2021 $0.67
Sga Expense Q2 2023 · Sep 30, 2022 $116.96M
Sga Expense Q2 2023 · Sep 30, 2022 $234.95M
Sga Expense Q2 2023 · Sep 30, 2021 $102.78M
Sga Expense Q2 2023 · Sep 30, 2021 $206.26M
Rd Expense Q2 2023 · Sep 30, 2022 $42.09M
Rd Expense Q2 2023 · Sep 30, 2022 $82.57M
Rd Expense Q2 2023 · Sep 30, 2021 $41.04M
Rd Expense Q2 2023 · Sep 30, 2021 $78.75M
Net Income Q2 2023 · Sep 30, 2022 $106.13M
Net Income Q2 2023 · Sep 30, 2022 $160.69M
Net Income Q2 2023 · Jun 30, 2022 $54.55M
Net Income Q2 2023 · Sep 30, 2021 $56.95M
Net Income Q2 2023 · Sep 30, 2021 $30.43M
Net Income Q2 2023 · Jun 30, 2021 −$26.53M
Operating Income Q2 2023 · Sep 30, 2022 $57.99M
Operating Income Q2 2023 · Sep 30, 2022 $124.04M
Operating Income Q2 2023 · Sep 30, 2021 $60.44M
Operating Income Q2 2023 · Sep 30, 2021 $11.15M
Revenue Q2 2023 · Sep 30, 2022 $265.92M
Revenue Q2 2023 · Sep 30, 2022 $543.07M
Revenue Q2 2023 · Sep 30, 2021 $248.14M
Revenue Q2 2023 · Sep 30, 2021 $500.73M